Carlsmed (CARL) EBIT Margin (2024 - 2026)
Carlsmed (CARL) posted EBIT Margin of 57.56% for Q1 2026, up 6.33% on a QoQ basis from 61.44% in Q4 2025, and down 143.0% year-over-year from 133.86% in Q1 2025.
Carlsmed (CARL) EBIT Margin (2024 - 2026) Analysis & Trends
Carlsmed's EBIT Margin history runs 3 years deep, the most recent figure standing at 57.56% for Q1 2026.
- Quarterly EBIT Margin fell 143.0% year-over-year to 57.56% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 60.48% (up 1549.0% YoY) and the FY2025 annual result came in at 60.53%, up 2827.0% from the prior year.
- EBIT Margin was 57.56% for Q1 2026 at Carlsmed, up from 61.44% in the prior quarter.
- Across five years, EBIT Margin topped out at 49.93% in Q4 2024 and bottomed at 118.01% in Q3 2024.
- A 3-year average of 71.24% and a median of 59.5% in 2025 frame the typical range for EBIT Margin.
- Peak annual rise in EBIT Margin reached 5010 bps in 2025, while the deepest fall reached 1152 bps in 2025.
- Carlsmed's EBIT Margin stood at 49.93% in 2024, then fell by 23 bps to 61.44% in 2025, then rose by 6 bps to 57.56% in 2026.
- Business Quant data shows CARL's EBIT Margin at 57.56% in Q1 2026, 61.44% in Q4 2025, and 69.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 29.03% |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -11.30% |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 17.59% |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 25.64% |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 17.08% |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 1.23% |
| 10 | Carlsmed | 295.19 Mn | 222.08 Mn | 12.43 Mn | -57.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.56% |
| Dec 31, 2025 | -61.44% |
| Sep 30, 2025 | -69.11% |
| Jun 30, 2025 | -53.81% |
| Mar 31, 2025 | -56.13% |
| Dec 31, 2024 | -49.93% |
| Sep 30, 2024 | -118.01% |
| Jun 30, 2024 | -103.91% |